Drug-Related Side Effects and Adverse Reactions Clinical Trial
Official title:
The Preventive Effect of Topical EGF Cream for Dermatologic Adverse Events Related to EGFR Inhibitors
The purpose of this study is to evaluate the preventive efficacy of topical EGF cream for dermatologic adverse events related to EGFR inhibitors.
Epidermal growth factor receptor(EGFR) is involved in cell proliferation and is
overexpressed or abnormally activated in malignant tumors originating from the colon,
breast, ovary, pancreas, and lung. EGFR tyrosine kinase inhibitor(TKI), gefitinib,
erlotinib, and afatinib have been for the treatment of cancer associated with EGFR gene
mutation. In addition, monoclonal antibodies to EGFR, such as cetuximab and panitumumab,
have been used as a chemotherapy for rectal cancer without ras gene mutation and advanced
head and neck cancer.
The incidence of cutaneous toxicity of EGFR inhibitors is reported to be 75-80%. Clinical
features include acneform folliculitis, xerosis, paronychia, and itching. Of these, about
10% of patients with Grade 3 or greater have a detrimental effect on quality of life and
adherence to treatment, resulting in impaired therapeutic results.
There have been many attempts to prevent or treat such skin toxicity. However, there has
been no scientifically proven treatment until now.
There is a growing interest in the role of EGF emulsifiers in the treatment of skin adverse
effects of EGFR inhibitors, as a result of studies that improve acne significantly compared
to placebo.
The purpose of this study is to evaluate the preventive efficacy of EGF cream in the
treatment of skin adverse effects in patients with malignant tumors treated with EGFR
inhibitor (TKI or monoclonal antibody).
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03258151 -
Association of Genetic Polymorphisms With Docetaxel-based Chemotherapy Toxicities in Chinese Solid Tumor Patients
|
||
Recruiting |
NCT05202964 -
Compliance and Tolerance to Oral AntiBiotherapy in Osteoarticular Infections (OTABIO)
|
||
Completed |
NCT04597593 -
Association Between Genetic Variant Scores and DOACs (DARES2)
|
||
Recruiting |
NCT05096338 -
Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Prostate Cancer
|
||
Recruiting |
NCT05078190 -
Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Breast Cancer
|
||
Completed |
NCT02457039 -
Acupuncture Prevents Chemobrain in Breast Cancer Patients
|
N/A | |
Completed |
NCT02779530 -
CYP4A11 and CYP4F2 Gene Variants as Makers of Cardiovascular Adverse Events of Non-steroidal Anti-inflammatory Drugs
|
Phase 4 | |
Recruiting |
NCT03047863 -
Therapeutic Effect of EGF Cream for Cutaneous Adverse Event of EGFR Inhibitors
|
N/A | |
Completed |
NCT02482025 -
The Secure Messaging for Medication Reconciliation Tool (SMMRT) Trial
|
N/A | |
Not yet recruiting |
NCT03147157 -
The Effect of Human Leukocyte Antigen Macthing on Guiding Tacrolimus Regimen After Liver Transplantation
|
N/A | |
Recruiting |
NCT03156348 -
Impact of Clinical Pharmacist on Adverse Drug Events in Older Adults
|
N/A | |
Recruiting |
NCT03501108 -
Discontinuation of Long-term Medications in Older People Entering Nursing Home Care
|
N/A | |
Recruiting |
NCT06427317 -
Routinely Collected Clinical Data and Evaluation of Antimicrobial Target Attainment
|
||
Completed |
NCT03227653 -
Neuropsychiatric Side Effects of Efavirenz in Children Living With HIV
|
||
Completed |
NCT03177174 -
Different Chemotherapy Protocols Combined With Intensity Modulated Radiation Therapy in Patients With Locally Advanced Nasopharyngeal Carcinoma
|
N/A | |
Recruiting |
NCT04077281 -
Improving Medication Prescribing-Related Outcomes for Vulnerable Elderly In Transitions
|
N/A | |
Not yet recruiting |
NCT05247814 -
Individual Risk Profiles for Adverse Drug Reactions in Geriatric Patients
|
||
Recruiting |
NCT03938597 -
Investigation of Serious Adverse Events Following Vaccination Against Yellow Fever: Emphasis on Genetic Basis and Biological Markers
|
||
Recruiting |
NCT06291688 -
Applying Mobile Healthcare Education to Improve Cutaneous Self-care Capability
|
N/A | |
Active, not recruiting |
NCT02119078 -
Acute Care for Elders (ACE) Program at OHSU Hospital
|
N/A |